Dishman Carbogen Amcis Limited (NSE:DCAL)
India · Delayed Price · Currency is INR 210.59
-0.57 (-0.27%)
Feb 5, 2026, 9:39 AM IST
Dishman Carbogen Amcis Market Cap
Dishman Carbogen Amcis has a market cap or net worth of 33.11 billion as of February 4, 2026. Its market cap has decreased by -16.44% in one year.
Market Cap
33.11B
Enterprise Value
52.38B
Revenue
27.97B
Ranking
n/a
PE Ratio
27.85
Stock Price
210.59
Market Cap Chart
Since September 21, 2017, Dishman Carbogen Amcis's market cap has decreased from 56.82B to 33.11B, a decrease of -41.73%. That is a compound annual growth rate of -6.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 33.11B | -14.71% |
| Dec 31, 2025 | 38.82B | -8.46% |
| Dec 31, 2024 | 42.41B | 58.22% |
| Dec 29, 2023 | 26.80B | 80.14% |
| Dec 30, 2022 | 14.88B | -52.91% |
| Dec 31, 2021 | 31.60B | 45.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 595.88B |
| Anthem Biosciences | 330.14B |
| OneSource Specialty Pharma | 134.60B |
| Concord Biotech | 119.21B |
| Blue Jet Healthcare | 71.13B |
| Supriya Lifescience | 53.56B |
| Zota Health Care | 39.08B |
| Panacea Biotec | 22.48B |